Safely manage your Zendesk from the AI assistant you already use, via the Deltastring MCP. Beacon configuration platform
← Back to news

CHWY Is Tapping AI and Pet Health to Expand Margins in 2026

Chewy is pursuing a dual-lever strategy to expand margins in 2026 by embedding AI across customer service, pharmacy operations and fulfillment workflows whilst simultaneously building out a healthcare platform through acquisitions and partnerships. The healthcare expansion—spanning vet clinics, pharmacy capabilities, PracticeHub and brands like SmartPak and Modern Animal—aims to deepen customer relationships beyond transactional pet supplies, with roughly 40% of Vet Care customers being new to Chewy and generating approximately $900 in year-one net sales per active customer. AI investments are expected to deliver low tens of millions in efficiency gains this fiscal year, with a larger ramp anticipated in 2027, whilst also supporting personalisation and marketing productivity. The margin story is already showing traction: Q1 fiscal 2026 saw gross margin expand 50 basis points to 30.1% and adjusted EBITDA margin widen 130 basis points to 7.5%, driven by sponsored ads, supply-chain efficiencies and operating discipline.

For CX teams, this signals a critical shift in how customer service infrastructure must evolve to support integrated healthcare workflows. Chewy's strategy requires seamless handoffs between transactional support, clinical guidance and pharmacy operations—a complexity that demands more sophisticated routing, knowledge management and agent training than traditional e-commerce support. The question for support leaders is whether your current platform architecture can handle this convergence: can your Zendesk or Freshdesk instance manage the contextual depth needed when a customer interaction spans product recommendations, veterinary advice and prescription management simultaneously? This is not simply about deploying AI chatbots; it's about building service models where AI augments human judgment in high-stakes healthcare contexts.

The execution risk, however, remains substantial. Chewy has lowered its fiscal 2026 net sales guidance and acknowledged softening consumer demand for premiumisation and product attachment—the very behaviours that would unlock revenue growth from its healthcare investments. If customers remain focused on essentials rather than expanding their spending across categories, the healthcare platform becomes a cost centre rather than a growth engine, and AI efficiency gains become the primary margin driver. For support teams already stretched thin, this creates a tension: you may be asked to absorb AI-driven productivity expectations whilst simultaneously handling more complex, lower-volume healthcare interactions that resist automation. The real test is whether Chewy can prove that healthcare depth and AI efficiency are mutually reinforcing rather than competing priorities.